Cargando…

Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated

BACKGROUND: Despite its benefits, a major concern regarding antipsychotic treatment is its possible impact on the brain’s structure and function. This study sought to explore the characteristics of white matter structural networks in chronic never-treated schizophrenia and those treated with clozapi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Chunyan, Lencer, Rebekka, Hu, Na, Xiao, Yuan, Zhang, Wenjing, Li, Siyi, Lui, Su, Gong, Qiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770521/ https://www.ncbi.nlm.nih.gov/pubmed/32808036 http://dx.doi.org/10.1093/ijnp/pyaa061

Ejemplares similares

Characteristics of the corpus callosum in chronic schizophrenia treated with clozapine or risperidone and those never-treated
por: Tao, Bo, et al.
Publicado: (2021)

Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients
por: Liu, Nian, et al.
Publicado: (2020)

Grey matter connectome abnormalities and age-related effects in antipsychotic-naive schizophrenia
por: Yang, Beisheng, et al.
Publicado: (2021)

Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia
por: Yang, Mi, et al.
Publicado: (2020)

Akathisia rate among psychiatric patients treated with Clozapine compared to Risperidone.
por: Stryjer, R., et al.
Publicado: (2023)

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Clozapine and risperidone influence on cortisol and estradiol levels in male patients with schizophrenia
por: Piriu, G, et al.
Publicado: (2015)

Abnormal dynamic functional connectivity between speech and auditory areas in schizophrenia patients with auditory hallucinations
por: Zhang, Wenjing, et al.
Publicado: (2018)

PM527. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics
por: Melkersson, Kristina, et al.
Publicado: (2016)

Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
por: Olfson, Mark, et al.
Publicado: (2007)

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
por: Liu-Seifert, Hong, et al.
Publicado: (2009)

Similar and Different Gray Matter Deficits in Schizophrenia Patients and Their Unaffected Biological Relatives
por: Xiao, Yuan, et al.
Publicado: (2013)

Cerebral and behavioral signs of impaired cognitive flexibility and stability in schizophrenia spectrum disorders
por: Standke, Isabel, et al.
Publicado: (2021)

Impaired dynamic functional brain properties and their relationship to symptoms in never treated first-episode patients with schizophrenia
por: You, Wanfang, et al.
Publicado: (2022)

A White Matter Connection of Schizophrenia and Alzheimer’s Disease
por: Kochunov, Peter, et al.
Publicado: (2020)

Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
por: Lee, Bong Ju, et al.
Publicado: (2013)

Sexual dysfunction in male schizophrenia remitted patients treated with risperidone and olanzapine
Publicado: (2022)

Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone
por: Kraguljac, Nina Vanessa, et al.
Publicado: (2015)

Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia
por: McQueen, Grant, et al.
Publicado: (2021)

Comparative study of clozapine versus risperidone in treatment-naive, first-episode schizophrenia: A pilot study
por: Sahni, Sukhtej, et al.
Publicado: (2016)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

White matter changes in treatment refractory schizophrenia: Does cognitive control and myelination matter?
por: Vanes, Lucy D., et al.
Publicado: (2018)

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs, Larry, et al.
Publicado: (2013)

Dissociations in cortical thickness and surface area in non-comorbid never-treated patients with social anxiety disorder
por: Zhang, Xun, et al.
Publicado: (2020)

Neurological Soft Signs Are Associated With Altered White Matter in Patients With Schizophrenia
por: Viher, Petra Verena, et al.
Publicado: (2021)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia
por: Sathish Kumar, S. V., et al.
Publicado: (2015)

Randomized, double‐blind, 6‐week non‐inferiority study of lurasidone and risperidone for the treatment of schizophrenia
por: Feng, Yuan, et al.
Publicado: (2020)

Early changes in white matter predict intellectual outcome in children treated for posterior fossa tumors()
por: Partanen, Marita, et al.
Publicado: (2018)

Electroconvulsive therapy in a patient with resistant paranoid schizophrenia treated with clozapine
por: Castelao-Almodóvar, S., et al.
Publicado: (2021)

Resistant schizophrenia in a patient with oculocutaneous albinism successfully treated with clozapine
por: Jelti, A., et al.
Publicado: (2022)

Altered white matter microarchitecture in amyotrophic lateral sclerosis: A voxel-based meta-analysis of diffusion tensor imaging
por: Zhang, Feifei, et al.
Publicado: (2018)

Cerebral white matter structure is associated with DSM-5 schizophrenia symptom dimensions
por: Viher, Petra V., et al.
Publicado: (2016)

M68. COGNITIVE IMPAIRMENT IN NEVER-TREATED SCHIZOPHRENIA SPECTRUM INDIVIDUALS
por: Solis-Vivanco, Rodolfo, et al.
Publicado: (2020)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
por: Tasaki, Minami, et al.
Publicado: (2021)

Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
por: Gao, Zhiyong, et al.
Publicado: (2023)

Aberrant Gray Matter Networks in Non-comorbid Medication-Naive Patients With Major Depressive Disorder and Those With Social Anxiety Disorder
por: Zhao, Youjin, et al.
Publicado: (2020)

Abnormal white matter microstructure and increased extracellular free-water in the cingulum bundle associated with delusions in chronic schizophrenia
por: Oestreich, Lena K.L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3eqnam9uc4kaoa81feave5i15e